As 2019 comes to a close and a promising new decade approaches, we’re getting excited to join regulators and clinical research professionals for the Virtual Clinical Trials Conference December 2 – 3 in Philadelphia, PA. This first-of-its-kind educational event will bring together industry leaders to gain in-depth insight into a critical shift in our industry.
Why are virtual (decentralized) clinical trials so important?
• 70% of study participants live more than 2 hours from research sites
• 85% of trials fail to enroll enough patients
• 30% of trial participants drop out
These numbers don’t have to be this high. With the growing use of everyday technology already standard in other highly-regulated industries, a new patient-centric paradigm is emerging. This paradigm is setting in motion a virtuous cycle that encourages patient diversity, takes the burden of participation of the patient’s shoulders, and empowers researchers to accelerate their work and get higher-quality data.
This conference, which we’re proud to sponsor, welcomes representatives from pharma, medical device, diagnostics, and biotech companies. There will be networking opportunities, panel discussions, case studies, and presentations on everything from the evolution of decentralized trials, to monitoring, regulations, and more. Here are just a few things we’re looking forward to learning at this landmark event:
Understand the decentralized model and determine when it’s the best fit
While there is an increasing number of cases showing the success of decentralized trials, they’re not a panacea for research challenges. Some trials may not be suitable for this model, while others are best off incorporating only some decentralized elements.
A central point of discussion at this event will be identifying challenges in decentralized trial adoption and determining the best fit. On the first day of the conference, we’re excited to take in lessons learned from decentralized, hybrid, and siteless modes, and for a case study that will discuss overcoming VCT operational challenges.
Learn how to develop a robust protocol and ensure trial success
The protocol is the foundation of any clinical trial, and with shifts in technology come critical new considerations. To combat costs and complexity, and to effectively use new technology, it’s crucial to stay up-to-date on success strategies.
There will be a panel on improving safety in device and diagnostics, sharing insight into using decentralized trials to enhance safety in monitoring, and determining endpoints for device effectiveness. Additionally, we’re excited about other presentations on how to leverage an ecosystem of new technologies in different therapeutic areas for risk management and oversight.
Understand regulatory challenges and ensure compliance
Until now, some of the biggest concerns we hear about using new technology in clinical trials are related to compliance. While the FDA and other regulators around the world support the use of new tech, the industry is still showing some hesitation to adopt.
At the end of the second day, we’re enthusiastic to hear from an FDA officer sharing insight into the current regulatory landscape, regulatory submission involving decentralized trials, as well as compliance for electronic informed consent. The final talk of the conference will be from a legal counselor, giving advice on vendor selection for new technology and data sharing considerations.
As a new decade approaches, we’re optimistically looking ahead at the incredible possibilities on the horizon for public health. The Virtual Clinical Trials conference is going to be one of the most educational and memorable of the year – and we can’t wait.
If you’re interested in participating, there’s still some time to register. Be sure to enter the discount code below to get 15% off your registration. We hope to see you there!